LGR4 and neoplasm: In univariate analysis, high expression of GPR48/LGR4 was significantly associated with several clinicopathologic parameters including tumor size (P=0.050), LN metastasis (P=0.004), locoregional recurrence (P=0.037), and presence of BRAFV600E (P=0.003) (Table 2).